Product Name: Evacetrapib
Chemical Name: (1S,4r)-4-(((S)-5-((3,5-bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methyl)cyclohexanecarboxylic acid
SMILES Code: O=C([C@H]1CC[C@H](CN2C3=C(C)C=C(C)C=C3[C@@H](N(CC4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4)C5=NN(C)N=N5)CCC2)CC1)O
CAS NO: 54970-72-8 Product: Bruceantin
Synonym: LY2484595; LY 2484595; LY-2484595
Chemical Formula: C31H36F6N6O2
Appearance: Solid powderWeb Site：Medchemexpress
Purity: 98% (this data is for the first batch)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 8211; 4 C for short term (days to weeks) or -20 C for long term (months to years).Protein_Tyrosine_Kinase_Compound_Library inhibitors
Solubility: Soluble in DMSO, not in water
Background Description: Evacetrapib (LY2484595) is a CETP inhibitor currently under development by Eli Lilly & Company. LY2484595 inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein. ItPubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/17637810
